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Abstract
Context: Patients with chronic fatigue syndrome and those with orthostatic intolerance share
many symptoms, yet questions exist as to whether CFS patients have physiological evidence of
orthostatic intolerance.
Objective: To determine if some CFS patients have increased rates of orthostatic hypotension,
hypertension, tachycardia, or hypocapnia relative to age-matched controls.
Design: Assess blood pressure, heart rate, respiratory rate, end tidal CO2 and visual analog scales
for orthostatic symptoms when supine and when standing for 8 minutes without moving legs.
Setting: Referral practice and research center.
Participants: 60 women and 15 men with CFS and 36 women and 4 men serving as age matched
controls with analyses confined to 62 patients and 35 controls showing either normal orthostatic
testing or a physiological abnormal test.
Main outcome measures: Orthostatic tachycardia; orthostatic hypotension; orthostatic
hypertension; orthostatic hypocapnia or combinations thereof.
Results: CFS patients had higher rates of abnormal tests than controls (53% vs 20%, p < .002), but
rates of orthostatic tachycardia, orthostatic hypotension, and orthostatic hypertension did not
differ significantly between patients and controls (11.3% vs 5.7%, 6.5% vs 2.9%, 19.4% vs 11.4%,
respectively). In contrast, rates of orthostatic hypocapnia were significantly higher in CFS than in
controls (20.6% vs 2.9%, p < .02). This CFS group reported significantly more feelings of illness and
shortness of breath than either controls or CFS patients with normal physiological tests.
Conclusion: A substantial number of CFS patients have orthostatic intolerance in the form of
orthostatic hypocapnia. This allows subgrouping of patients with CFS and thus reduces patient pool
heterogeneity engendered by use of a clinical case definition.
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Background
Chronic fatigue syndrome (CFS) is an ailment character-
ized by medically unexplained fatigue, severe enough to
produce a substantial decrease in activity plus infectious,
rheumatological and neuro-psychiatric symptoms. Ortho-
static intolerance (OI) is defined by medically unex-
plained symptoms of lightheadedness, fatigue,
neurocognitive deficits, nausea, abdominal pain, and
shortness of breath when upright and improved by
recumbency; patients with OI often have a chronic prob-
lem with fatigue even when not standing [1]. CFS patients
commonly complain of symptom worsening during
standing [2], and one early study reported that 22 of 23
CFS patients reported symptom worsening during orthos-
tatic challenge. [3]. This association led to the hypothesis
that some CFS patients had orthostatic intolerance which
could be identified, quantified, and specifically treated.
Evaluation for OI in CFS has usually focused on abnor-
malities of heart rate and blood pressure control. An early
report noted a high rate of delayed, neurally mediated
hypotension (NMH) during upright tilt table testing of
CFS patients. [3]. Although there is evidence in support of
more NMH in CFS patients than healthy controls [4,5],
two carefully controlled studies matching patients to con-
trols found no difference in prevalence of this orthostatic
syndrome [6,7]. A second symptomatic physiological
abnormality occurring in CFS patients was reported to be
orthostatic tachycardia. However, some groups reported
increased rates of this physiological marker of orthostatic
intolerance in CFS [8,9] while others did not [10]. One
recent population-based study found no evidence for OI
in CFS [11]. Thus, the existence of OI in CFS remains con-
troversial.
A recent report noted that cardiovascular measures of OI
in patients with CFS were often accompanied by hypocap-
nia, a pulmonary manifestation of OI where blood carbon
dioxide is at lower levels than normal [9]. Since respira-
tory indices had not previously been assessed during
orthostatic challenge, this report led us to hypothesize
that the primary manifestation of OI in CFS might be
orthostatic hypocapnia. To investigate this hypothesis, we
performed standing tests in CFS patients and in age- and
sex-matched healthy volunteers.
Methods
The subjects were 75 patients (60 women and 15 men)
fulfilling the 1994 case definition for CFS. [12]. Thus all
these patients reported having new onset of fatigue that
was severe enough to produce a substantial decrease in
activity as well as having problems with at least four of
eight infectious, rheumatological or neuropsychiatric
symptoms. No medical explanation for the fatigue could
be found with a set of rule-out blood tests including thy-
roid and liver panels, CBC, Lyme titer, ANA, and rheuma-
toid factor. The patients came either from a tertiary care
practice devoted to medically unexplained illnesses or as
volunteers responding to media reports on our research;
they were evaluated regardless of medication regimen.
Because earlier work had suggested an association
between CFS illness severity and cardiac function. [13],
patients were stratified into "severe" and "not severe"
groups (30 and 45, respectively). "Severe CFS" was
defined as those patients also fulfilling the more demand-
ing 1988 case definition for CFS [14] and endorsing at
least seven of the minor symptoms as producing substan-
tial, severe or very severe problems for the patient in the
month prior to intake (i.e., ≥ 3 on zero to five Likert
scales). Subjects also included 40 age matched controls
reporting themselves to be in excellent or good health and
not taking any medications other than birth control pills
(36 women and 4 men). The controls came from a data
base of individuals interested in participating in research
or via recruitment by research staff.
After giving informed consent, subjects filled out a ques-
tionnaire to assess current mood (Centers for Epidemio-
logical Study-Depression. [15]) and were instrumented
with a blood pressure cuff (OMRON HEM-711AC Intelli-
Sense Automatic Blood Pressure Monitor) to allow auto-
matic determination of blood pressure and heart rate and
a nasal cannula to allow automatic determination of res-
piratory rate and end tidal CO2 (Oridion Microstream).
Subjects were instructed in the use of visual analog scales
to indicate their levels of dizziness, anxiety, shortness of
breath, and of feeling ill (10 cm horizontal lines ranging
from "not at all" to "as ____ as I can imagine." They were
allowed to lie undisturbed for 10 minutes and then each
of the above variables were recorded twice – one minute
apart – with the subject in the supine position. Then, sub-
jects were asked to stand with their feet about 8 inches
from a wall; they were then told to lean back, touching
only their upper back to the wall and not allowing move-
ment of their legs for 8 minutes. This is a variant of a test
used by NASA researchers to test for OI [16]; it reduces
muscular influences on venous return, a major cause of
variability in orthostatic testing. Heart rate, respiratory
rate, blood pressure and eTCO2 as well as self report data
of symptom severity were collected every minute while
leaning upright.
Orthostatic tachycardia was defined as (a) more than one
standing reading showing an increase from baseline of ≥
30 beats per minute or an absolute rate of 120 beats per
minute or (b) one such reading prior to subjects' being
unable to tolerate further standing. Orthostatic hyperten-
sion was defined as (a) more than one standing systolic
reading of ≥ 140 mmHg or diastolic reading of ≥ 90
mmHg or (b) one such systolic or diastolic reading priorDynamic Medicine 2007, 6:2 http://www.dynamic-med.com/content/6/1/2
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to subjects' being unable to tolerate further standing.
Orthostatic hypotension was defined as (a) more than
one standing reading showing a drop of blood pressure of
≥ 20 mmHg systolic or 10 mmHg diastolic or (b) one such
reading prior to subjects' being unable to tolerate further
standing. Orthostatic hypocapnia was defined as (a) more
than one standing reading of ≤ 30 mmHg eTCO2 or (b)
one such reading prior to subjects' being unable to toler-
ate further standing. The presence of orthostatic tachycar-
dia, orthostatic hypotension, orthostatic hypertension, or
orthostatic hypocapnia defined an abnormal standing
test.
Data analysis and statistics
Statistical analysis to determine differences of "count"
data between CFS and controls used Fisher's tests, and dif-
ferences of continuous data used one-way ANOVAs with
subsequent Bonferroni tests; when p values are given for
individual post-hoc comparisons, the overall F value was
significant to < .05. For data with repeated measures, hier-
archical linear modeling (SPSS, Mixed) was done to assess
differences from mean supine to standing values among
groups. While we had a complete data set for physiologi-
cal measures, we did not have self report data from 25
patients and 5 controls as we only began collecting these
data after we realized they would be needed to evaluate
the possibility that anxiety or depressed mood might
explain our findings. Results are presented as means ±
s.e.m. unless otherwise specified.
Results
Because of the possibility that one abnormal reading
while standing might have been an erroneous reading, we
dropped data from subjects with only one abnormal
blood pressure or one eTCO2 value in the absence of
orthostatic symptoms (4 controls and 5 CFS and 1 control
and 3 CFS respectively). In addition, we excluded from
further analysis data from 3 CFS patients with baseline
end tidal C02 values ≥ 30 mmHg because they appeared
to be chronic hyperventilators [17]. Including the data
from all these subjects would not have changed the over-
all results of this study. Finally two CFS patients on treat-
ment for hypertension developed orthostatic
hypotension, and so their data were also dropped. Follow-
ing these exclusions, we analyzed the data from 62 CFS
patients and 35 controls.
There was no significant difference in age between
patients and controls (43.3 ± 10.5 [sd] years and 40.4 ±
7.9). Significantly more CFS patients than controls ful-
filled our criteria for abnormal standing tests (53% vs
20%, p < .002). For both groups, abnormalities were
mostly confined to one parameter – heart rate, blood pres-
sure or end tidal CO2 (see Table 1). Rates of orthostatic
tachycardia, orthostatic hypotension, and orthostatic
hypertension did not differ significantly between patients
and controls (11.3% vs 5.7%, 6.5% vs 2.9%, 19.4% vs
11.4%, respectively; note that some subjects had more
than one form of OI). However rates of orthostatic hypoc-
apnia were significantly higher in CFS than in controls
(20.6% vs 2.9%, p < .02). The first occurrence of a hypoc-
apnic value occurred in the first 3 minutes of standing for
8 of the 13 subjects. However, the magnitude of hypocap-
nia increased over time (see Figure 1).
In an effort to evaluate possible variables producing
orthostatic hypocapnia, we did a post-hoc analysis con-
fined to CFS patients with orthostatic hypocapnia (n = 13)
with two comparison groups – CFS patients with normal
physiological responses to orthostatic challenge (n = 30)
and healthy subjects with normal physiological responses
to orthostatic challenge (n = 28).
There was no difference in rates of "severe CFS" between
patients with orthostatic hypocapnia and patients with no
orthostatic intolerance (38% vs 30%). There was no dif-
ference in the change in respiratory rates from supine to
standing among groups; however both CFS groups tended
to breath slower while supine than controls (orthostatic
hypocapnia: 15.4 ± 1.4; no intolerance: 16.1 ± 0.6; con-
trols: 18.5 ± 0.6; p = .052 and .06 for each comparison).
There were no differences among the 3 groups for supine
systolic/diastolic blood pressure or for heart rate while
supine or for the magnitude of change when standing.
During orthostatic challenge, end tidal CO2 values
showed a small decline over time for the CFS group with-
out orthostatic intolerance and the controls (F7,185.5 =
2.89, p < .001); this effect of orthostatic challenge on nor-
mals has been previously reported [18].
Anxiety and illness ratings in the supine position were
higher in both CFS groups than in the controls (p < .04 for
comparisons on anxiety and < .001 on illness). Ratings of
shortness of breath and dizziness in the supine position
did not differ among groups.
Magnitude of change in anxiety did not differ among
groups going from supine to standing. Magnitude of
change in feeling ill ratings going from supine to standing
increased for the CFS group with orthostatic hypocapnia
but not for the other CFS group or the controls (F [Int]7,60.5
= 4.14; p < .001). Magnitude of change in shortness of
breath going from supine to standing was significantly
greater for the CFS group with orthostatic hypocapnia
than the CFS group without orthostatic intolerance (F1,30.4
= 4.44, p < .05). Both CFS groups reported a greater
increase in shortness of breath while standing compared
to controls (p < .005 for both comparisons). In terms of
increases in dizziness ratings going from supine to stand-
ing, it was the CFS group without orthostatic abnormali-Dynamic Medicine 2007, 6:2 http://www.dynamic-med.com/content/6/1/2
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ties that was higher than controls (F1,47.3 = 14.2, p < .001)
with the CFS group with hypocapnia being intermediary.
There was no significant difference in depressed mood
between the 2 CFS groups as assessed by the CES-D, but
both were significantly higher than controls (p < .001;
medians for those with orthostatic hypocapnia, no ortho-
static intolerance and controls, respectively were 20.5,
19.5, 6.0).
Discussion
We used a simple, real-life orthostatic challenge to deter-
mine rates of the different physiological manifestations of
orthostatic intolerance in CFS. Previous studies of orthos-
Table 1: Rates of Normal and Different Abnormal Standing Tests
CFS Controls
Normal 30 28
Orthostatic tachycardia (OT) alone 5 1
Orthostatic hypertension (HT) alone 9 4
Orthostatic hypertension (HT) plus OT 1 0
Orthostatic hypotension (ht) alone 4 1
Orthostatic hypocapnia alone 11 0
Orthostatic hypocapnia plus OT 0 1
Orthostatic hypocapnia plus HT 1 0
Orthostatic hypocapnia plus HT plus OT 1 0
Total Normal/Abnormal 30/32 28/7
End tidal CO2 (mmHg) and time (min) before and after upright leaning Figure 1
End tidal CO2 (mmHg) and time (min) before and after upright leaning. Data are presented as means ± sem over time. Subjects 
were in the supine position at -1 and 0 and then stood up, leaning their upper backs against a wall without moving their legs. 
Both controls and CFS patients without orthostatic intolerance showed a small decline in eTCO2 over time. In contrast, the 
fall in those with orthostatic hypocapnia was substantial.
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tatic intolerance in CFS have focused on changes in blood
pressure and heart rate with approximately 25% of
patients having these abnormalities. [19]. However,
orthostatic changes in heart rate and blood pressure are
not uncommon in healthy people too [4,11]. In our stud-
ies, CFS patients did show higher rates of orthostatic tach-
ycardia, hypertension, and hypotension than healthy
controls. However, the differences were not significant,
and substantially larger sample sizes would have been
necessary for significance to have emerged.
In contrast, 21% of CFS patients studied here compared to
only 3% of controls had orthostatic hypocapnia, usually
occurring without cardiovascular indices of OI. These
patients reported more problems with shortness of breath
and feeling ill during the orthostatic challenge than
patients without physiological evidence of OI or controls.
An earlier study using a longer duration orthostatic chal-
lenge – 30 min of head up tilt – noted hypocapnia to
occur in the presence of other cardiovascular indices of OI
[9]. That report as well as this one suggests that alterations
in respiration are the primary manifestation of OI in
patients with CFS. The identification of a subset of CFS
patients with this physiological manifestation of orthos-
tatic intolerance is important in that its existence can be
used as a stratification strategy to reduce the patient pool
heterogeneity inherent in using a clinical case definition
to diagnose CFS.
We thought we might find a relation between CFS illness
severity and orthostatic intolerance, but we did not. We
found the same rates of "severe CFS" in patients with
orthostatic hypocapnia as in patients without orthostatic
intolerance. In addition, we found no difference in rates
of clinically meaningful depression in the two CFS groups
as assessed by the CES-D. Whether some other illness-
related variable is predictive of orthostatic intolerance
remains to be determined.
One limitation in our study was that we evaluated succes-
sive patients in either a private practice or a research set-
ting regardless of whether or not they were taking
medicine. While we did drop data from two patients who
developed orthostatic hypotension due to their being on
anti-hypertensive medication, use of other medications
did not explain the tendency of patients to show more
orthostatic hypotension or tachycardia than controls. It is
not apparent why medications would produce orthostatic
hypocapnia in the absence of other syndromes of orthos-
tatic intolerance; however, this remains a possibility
which will require further study of unmedicated CFS
patients.
There are at least two explanations to account for orthos-
tatic hypocapnia – hyperventilation or reduced delivery of
CO2 to the lung secondary to reduced venous return to
the right side of the heart. If it were the latter, one would
expect transient hypocapnia occurring early during stand-
ing. Instead, we found that hypocapnia was sustained and
progressive, and the hypocapnia usually occurred without
other cardiovascular manifestations of orthostatic intoler-
ance. This analysis supports the idea that the hypocapnia
was due to hyperventilation; although we did not assess
ventilation in this study, we did in another study and
found hyperventilation in adolescents who became
hypocapnic during tilt testing [20]. But why orthostatic
hypocapnia develops as the primary mechanism for
developing symptoms of OI in CFS patients is an impor-
tant research question. Our data indicate that emotional
factors related to anxiety or depression are not important.
Our working hypothesis is that this phenomenon comes
from a complex interaction among the baroreflex, chem-
oreceptors, and thoracic blood volume. Nonetheless, the
occurrence of isolated orthostatic hypocapnia in CFS sug-
gests that it is an important marker for orthostatic intoler-
ance in some patients with medically unexplained fatigue,
which may eventually be susceptible to treatment. Find-
ing such a marker in a subgroup of CFS patients is the first
step in moving this illness from a clinical syndrome to
one diagnosable by laboratory testing.
Conclusion
The occurrence of isolated orthostatic hypocapnia in CFS
suggests that it is an important marker for orthostatic
intolerance in some patients with medically unexplained
fatigue, which may eventually be susceptible to treatment.
Finding such a marker in a subgroup of CFS patients is the
first step in reducing the patient pool heterogeneity
implicit in using a clinical case definition for diagnosis.
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